Keratinocyte-Specific Expression of Human Thrombomodulin in Transgenic Mice: Effects on Epidermal Differentiation and Cutaneous Wound Healing

Journal of Investigative Medicine

Volumn 46, Issue 4, 1998, Pages 127-133

  Raife, Thomas J ^a   Lager, Donna J ^b   Peterson, Jeffrey J ^b   Erger, Rochelle A ^c   Lentz, Steven R ^b,c  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epidermis; Keratinocyte; Squamous; Thrombin; Thrombomodulin

Indexed keywords

MUS MUSCULUS;

THROMBOMODULIN;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; EPIDERMIS; HUMAN; INJURY; KERATINOCYTE; METABOLISM; MOUSE; PHYSIOLOGY; SKIN; SPECIES DIFFERENCE; TRANSGENIC MOUSE; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; EPIDERMIS; HUMANS; KERATINOCYTES; MICE; MICE, TRANSGENIC; SKIN; SPECIES SPECIFICITY; THROMBOMODULIN; WOUND HEALING;

EID: 0032038825     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995;9:946-55.
2. Zoller B, Hillarp A, Berntorp E, Dahlback B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Ann Rev Med 1997;48:45-58.
3. Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996;271:16603-8.
4. Raife TJ, Lager DJ, Madison KC, Piette WW, Howard EJ, Sturm MT, Chen Y, Lentz SR. Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J Clin Invest 1994;93:1846-51.
5. Mizutani H, Hayashi T, Nouchi N, Ohyanagi S, Hashimoto K, Shimuzu M, Suzuki K. Functional and immunoreactive thrombomodulin expressed by keratinocytes. J Invest Dermatol 1994;103:825-8.
6. Jackson DE, Mitchell CA, Bird P, Salem HH, Hayman JA. Immunohistochemical localization of thrombomodulin in normal human skin and skin tumours. J Pathol 1995;175:421-32.
7. Senet P, Peyri N, Berard M, Dubertret L, Boffa MC. Thrombomodulin, a functional surface protein on human keratinocytes, is regulated by retinoic acid. Arch Dermatol Res 1997;289:151-7.
8. Lager DJ, Callaghan EJ, Worth SF, Raife TJ, Lentz SR. Cellular localization of thrombomodulin in human epithelium and squamous malignancies. Am J Pathol 1995;146:933-43.
9. Tezuka Y, Yonezawa S, Maruyama I, Matsushita Y, Shimizu T, Obama H, Sagara M, Shirao K, Kusano C, Natsugoe S, Yoshinaka H, Baba M, Fukumoto T, Aikou T, Sate E. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis. Cancer Res 1995;55:4196-200.
10. Raife TJ, Demetroulis EM, Lentz SR. Regulation of thrombomodulin expression by all-trans retinoic acid and tumor necrosis factor-α: differential responses in keratinocytes and endothelial cells. Blood 1996;88:2043-9.
11. Lager DJ, Raife TJ, Lentz SR, Kealey GP. Thrombomodulin expression in healing wounds correlates with keratinocyte stratification. Lab Invest [abstract]. 1996;74:146A.
12. Clark RAF. The molecular and cellular biology of wound repair. New York: Plenum, 1996.
13. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997;276:75-81.
14. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996;2:(3)287-92.
15. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996;87:709-19.
16. Tsiang M, Lentz SR, Sadler JE. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity. J Biol Chem 1992;267:6164-70.
17. Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci USA 1989;86:1563-7.
18. Nasir A, Ferbel B, Salminen W, Barth RK, Gaspari AA. Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen. J Clin Invest 1994;94:892-8.
19. Sambrook J, Fritsch EF, Maniatis T. Analysis and cloning of eukaryotic genomic DNA. In: Ford N, Nolan C, Ferguson M, eds. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989;9.1-9.62.
20. Dittman WA, Kumada T, Sadler JE, Majerus PW. The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J Biol Chem 1988;263:15815-22.
21. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 1996;98:24-9.
22. Ford VA, Wilkinson JE, Kennel SJ. Thrombomodulin distribution during murine development. Roux Arch Devel Biol 1993;202:364-70.
23. Sigmund CD. Major approaches for generating and analyzing transgenic mice. An overview. Hypertension 1993;22:599-607.
24. Dittman WA Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990;75:329-36.
25. Turksen K, Cooper T, Degenstein L, Williams I, Fuchs E. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci USA 1992;89:5068-72.
26. Wang X, Zinkel S, Polonsky K, Fuchs E. Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy. Proc Natl Acad Sci USA 1997;94:219-26.
27. Guo L, Yu QC, Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J 1993;12:973-86.
28. Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and post-transcriptional mechanisms. Blood 1991;77:542-50.
29. Kumada T, Dittman WA, Majerus PW. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood 1987;71:728-33.
30. Gomi K, Zushi M, Honda G, Kawahara S, Matsuzaki O, Kanabayashi T, Yamamoto S, Maruyama I, Suzuki K. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood 1990;75:1396-9.
31. Soils MM, Cook C, Cook J, Glaser C, light D, Morser J, Yu S, Fink L, Eidt JF. Intravenous recombinant soluble thrombomodulin prevents venous thrombosis in a rat model. J Vasc Surg 1991;14:599-604.
32. Ono M, Nawa K, Marumoto Y. Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis. Thromb Haemost 1994;72:421-5.
33. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997;78:386-91.
34. Jackson DE, Mitchell CA, Mason G, Salem HH, Hayman JA. Altered thrombomodulin staining in blistering dermatoses. Pathology 1996;28:225-8.
35. Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 1995;92:850-4.
36. Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost 1990;16:299-309.
37. Powars DR, Rogers ZR, Patch MJ, McGehee WG, Francis RB Jr. Purpura fulminans in meningococcemia: association with acquired deficiencies of protein C and protein S. N Engl J Med 1987;317:571-2.